BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 9737691)

  • 21. Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B.
    Herman JG; Jen J; Merlo A; Baylin SB
    Cancer Res; 1996 Feb; 56(4):722-7. PubMed ID: 8631003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methylation of the multi tumor suppressor gene-2 (MTS2, CDKN1, p15INK4B) in childhood acute lymphoblastic leukemia.
    Iravani M; Dhat R; Price CM
    Oncogene; 1997 Nov; 15(21):2609-14. PubMed ID: 9399648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel pre-B acute lymphoblastic leukemia cell line with chromosomal translocation between p16(INK4A)/p15(INK4B) tumor suppressor and immunoglobulin heavy chain genes: TGFbeta/IL-7 inhibitory signaling mechanism.
    Urashima M; Hoshi Y; Sugimoto Y; Kaihara C; Matsuzaki M; Chauhan D; Ogata A; Teoh G; DeCaprio JA; Anderson KC
    Leukemia; 1996 Oct; 10(10):1576-83. PubMed ID: 8847892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aberrant methylation of p16INK4a and deletion of p15INK4b are frequent events in human esophageal cancer in Linxian, China.
    Xing EP; Nie Y; Wang LD; Yang GY; Yang CS
    Carcinogenesis; 1999 Jan; 20(1):77-84. PubMed ID: 9934853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Universal inactivation of both p16 and p15 but not downstream components is an essential event in the pathogenesis of T-cell acute lymphoblastic leukemia.
    Omura-Minamisawa M; Diccianni MB; Batova A; Chang RC; Bridgeman LJ; Yu J; Pullen J; Bowman WP; Yu AL
    Clin Cancer Res; 2000 Apr; 6(4):1219-28. PubMed ID: 10778944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alterations of the p53, p21, p16, p15 and RAS genes in childhood T-cell acute lymphoblastic leukemia.
    Kawamura M; Ohnishi H; Guo SX; Sheng XM; Minegishi M; Hanada R; Horibe K; Hongo T; Kaneko Y; Bessho F; Yanagisawa M; Sekiya T; Hayashi Y
    Leuk Res; 1999 Feb; 23(2):115-26. PubMed ID: 10071127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Homozygous deletions of cyclin-dependent kinase inhibitor genes, p16(INK4A) and p18, in childhood T cell lineage acute lymphoblastic leukemias.
    Iolascon A; Faienza MF; Coppola B; della Ragione F; Schettini F; Biondi A
    Leukemia; 1996 Feb; 10(2):255-60. PubMed ID: 8637234
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Homozygous deletions at chromosome 9p21 involving p16 and p15 are associated with histologic progression in follicle center lymphoma.
    Elenitoba-Johnson KS; Gascoyne RD; Lim MS; Chhanabai M; Jaffe ES; Raffeld M
    Blood; 1998 Jun; 91(12):4677-85. PubMed ID: 9616165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oncogenic fusion E2A-HLF sensitizes t(17;19)-positive acute lymphoblastic leukemia to TRAIL-mediated apoptosis by upregulating the expression of death receptors.
    Zhang X; Inukai T; Hirose K; Akahane K; Kuroda I; Honna-Oshiro H; Kagami K; Goi K; Nakamura K; Kobayashi M; Endo M; Yagita H; Kurosawa H; Thomas Look A; Honda H; Inaba T; Nakazawa S; Sugita K
    Leukemia; 2012 Dec; 26(12):2483-93. PubMed ID: 22743623
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alterations of p16INK4A and p15INK4B genes in gastric carcinomas.
    Lee YY; Kang SH; Seo JY; Jung CW; Lee KU; Choe KJ; Kim BK; Kim NK; Koeffler HP; Bang YJ
    Cancer; 1997 Nov; 80(10):1889-96. PubMed ID: 9366289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Site-specific translocation and evidence of postnatal origin of the t(1;19) E2A-PBX1 fusion in childhood acute lymphoblastic leukemia.
    Wiemels JL; Leonard BC; Wang Y; Segal MR; Hunger SP; Smith MT; Crouse V; Ma X; Buffler PA; Pine SR
    Proc Natl Acad Sci U S A; 2002 Nov; 99(23):15101-6. PubMed ID: 12415113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of the t(17;19) translocation by gene-specific fluorescent in situ hybridization-based cytogenetics and detection of the E2A-HLF fusion transcript and protein in patients' cells.
    Yeung J; Kempski H; Neat M; Bailey S; Smith O; Brady HJ
    Haematologica; 2006 Mar; 91(3):422-4. PubMed ID: 16531271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas.
    Elisei R; Shiohara M; Koeffler HP; Fagin JA
    Cancer; 1998 Nov; 83(10):2185-93. PubMed ID: 9827724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monoclonal antibodies specific to the acute lymphoblastic leukemia t(1;19)-associated E2A/pbx1 chimeric protein: characterization and diagnostic utility.
    Sang BC; Shi L; Dias P; Liu L; Wei J; Wang ZX; Monell CR; Behm F; Gruenwald S
    Blood; 1997 Apr; 89(8):2909-14. PubMed ID: 9108411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Formation of der(19)t(1;19)(q23;p13) in acute lymphoblastic leukemia.
    Paulsson K; Horvat A; Fioretos T; Mitelman F; Johansson B
    Genes Chromosomes Cancer; 2005 Feb; 42(2):144-8. PubMed ID: 15543624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Establishment of a novel human B-cell line (OZ) with t(14;18)(q32;q21) and aberrant p53 expression was associated with the homozygous deletions of p15INK4B and p16INK4A genes.
    Nagai M; Fujita M; Ohmori M; Matsubara S; Taniwaki M; Horiike S; Tasaka T; Koeffler HP; Takahara J
    Hematol Oncol; 1997 Aug; 15(3):109-19. PubMed ID: 9600110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The commonly deleted region at 9p21-22 in lymphoblastic leukemias spans at least 400 kb and includes p16 but not p15 or the IFN gene cluster.
    Aguiar RC; Sill H; Goldman JM; Cross NC
    Leukemia; 1997 Feb; 11(2):233-8. PubMed ID: 9009086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deletion and differential expression of p16INK4a in mouse lung tumors.
    Belinsky SA; Swafford DS; Middleton SK; Kennedy CH; Tesfaigzi J
    Carcinogenesis; 1997 Jan; 18(1):115-20. PubMed ID: 9054597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p16INK4A and p15INK4B gene deletions in primary leukemias.
    Haidar MA; Cao XB; Manshouri T; Chan LL; Glassman A; Kantarjian HM; Keating MJ; Beran MS; Albitar M
    Blood; 1995 Jul; 86(1):311-5. PubMed ID: 7795238
    [TBL] [Abstract][Full Text] [Related]  

  • 40. E4BP4 expression is regulated by the t(17;19)-associated oncoprotein E2A-HLF in pro-B cells.
    Yeung J; O'Sullivan E; Hubank M; Brady HJ
    Br J Haematol; 2004 Jun; 125(5):560-7. PubMed ID: 15147370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.